RRAS2
Ras-related protein R-Ras2
Also known as: RRAS2_HUMAN, TC21
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62070
- Gene
- RRAS2
- Ensembl
- ENSG00000133818
- Chromosome
- 11
- Canonical length
- 204 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins
OverviewNCBI Gene
This gene encodes a member of the R-Ras subfamily of Ras-like small GTPases. The encoded protein associates with the plasma membrane and may function as a signal transducer. This protein may play an important role in activating signal transduction pathways that control cell proliferation. Mutations in this gene are associated with the growth of certain tumors. Pseudogenes of this gene are found on chromosomes 1 and 2. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
204 residues, UniProt reviewed canonical sequence.
>P62070|RRAS2
1 MAAAGWRDGS GQEKYRLVVV GGGGVGKSAL TIQFIQSYFV TDYDPTIEDS YTKQCVIDDR
61 AARLDILDTA GQEEFGAMRE QYMRTGEGFL LVFSVTDRGS FEEIYKFQRQ ILRVKDRDEF
121 PMILIGNKAD LDHQRQVTQE EGQQLARQLK VTYMEASAKI RMNVDQAFHE LVRVIRKFQE
181 QECPPSPEPT RKEKDKKGCH CVIFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RRAS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 42 nTPM
- skeletal muscle: 38 nTPM
- small intestine: 37 nTPM
- kidney: 37 nTPM
- liver: 37 nTPM
- tonsil: 35 nTPM
Single-cell type
- epicardial cells: 332 nCPM
- oocytes: 281 nCPM
- b-cells: 236 nCPM
- myonuclei: 230 nCPM
- ocular epithelial cells: 211 nCPM
- nk-cells: 182 nCPM
Immune cell
- memory B-cell: 12 nTPM
- naive B-cell: 6.6 nTPM
- gdT-cell: 5.5 nTPM
- NK-cell: 3.8 nTPM
- memory CD8 T-cell: 2.8 nTPM
- MAIT T-cell: 2.4 nTPM
Brain region
- choroid plexus: 32 nTPM
- hippocampal formation: 26 nTPM
- hypothalamus: 23 nTPM
- cerebellum: 21 nTPM
- cerebral cortex: 20 nTPM
- midbrain: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RRAS2.
Disease | AllUniProt
Conditions RRAS2 is implicated in, by any mechanism.
- Ovarian cancer (OC) MIM:167000
- Noonan syndrome 12 (NS12) MIM:618624
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 109 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Noonan syndrome
- Noonan syndrome 12
- Inborn genetic diseases
- Germinoma
- Ovarian neoplasm
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.78
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- osteoblast differentiation
- Ras protein signal transduction
- Schwann cell migration
- positive regulation of Schwann cell migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RRAS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RRAS2 as an antibody target. Whether an autoantibody or antibody against RRAS2 could matter depends on whether native RRAS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RRAS2 is annotated at the cell surface, where native RRAS2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RRAS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...